Tapewire

Nasdaq · USD

CHRS

Coherus Oncology, Inc.

Export transactions ↓
Tapewire entity
6276
SEC CIK
0001512762
Parsed reports
296

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 25, 2021 Filed Jan 27, 2021 16:15 UTC
Viret Jean-FredericChief Financial Officer
SaleCommon Stock 40,000 $20.10 $804,000.00
Disclosure

SEC source: 0001567619-21-001600 · doc1.xml · nonDerivative · entry 2

Viret Jean-Frederic · CIK 0001427569 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,439

F1 · kind: The sales reported in this Form 4 were effected pursuant to one or more Rule 10b5-1 trading plans adopted by Reporting Person.

F2 · balance_after: Includes 52,083 restricted stock units.

Read SEC document
January 25, 2021 Filed Jan 27, 2021 16:15 UTC
Viret Jean-FredericChief Financial Officer
Exercise / conversionCommon Stock 40,000 $10.05 $402,000.00
Disclosure

SEC source: 0001567619-21-001600 · doc1.xml · nonDerivative · entry 1

Viret Jean-Frederic · CIK 0001427569 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 107,439

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · balance_after: Includes 52,083 restricted stock units.

Read SEC document
January 23, 2021 Filed Jan 26, 2021 21:37 UTC
Lanfear Dennis MDirector · President & CEO
GrantStock Option (Right to Buy) · Derivative 500,000 $0.00 Strike: $18.33 $0.00
Disclosure

SEC source: 0001567619-21-001529 · doc1.xml · derivative · entry 1

Lanfear Dennis M · CIK 0001420822 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires 2031-01-23

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from January 23, 2021, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

Read SEC document
January 19, 2021 Filed Jan 21, 2021 21:22 UTC
Anicetti Vincent RChief Operating Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 2,500 $0.00 Strike: $2.50 $0.00
Disclosure

SEC source: 0001567619-21-001335 · doc1.xml · derivative · entry 3

Anicetti Vincent R · CIK 0001733375 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,488

Underlying: Common Stock · 2,500 shares

Expires 2024-06-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: All of the shares underlying this option are vested and exercisable as of the date hereof.

Read SEC document
January 19, 2021 Filed Jan 21, 2021 21:22 UTC
Anicetti Vincent RChief Operating Officer
SaleCommon Stock 2,500 $17.94 $44,852.00
Disclosure

SEC source: 0001567619-21-001335 · doc1.xml · nonDerivative · entry 2

Anicetti Vincent R · CIK 0001733375 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,739

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person.

F3 · price: The transaction was executed in multiple trades in prices ranging from $17.76 to $18.06, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.

F1 · balance_after: Includes 52,083 restricted stock units.

Read SEC document
January 19, 2021 Filed Jan 21, 2021 21:22 UTC
Anicetti Vincent RChief Operating Officer
Exercise / conversionCommon Stock 2,500 $2.50 $6,251.25
Disclosure

SEC source: 0001567619-21-001335 · doc1.xml · nonDerivative · entry 1

Anicetti Vincent R · CIK 0001733375 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,239

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 52,083 restricted stock units.

Read SEC document
January 11, 2021 Filed Jan 13, 2021 16:24 UTC
Vexler VladimirChief Scientific Officer
GrantStock Option (Right to Buy) · Derivative 62,500 $0.00 Strike: $17.58 $0.00
Disclosure

SEC source: 0001567619-21-000983 · doc1.xml · derivative · entry 2

Vexler Vladimir · CIK 0001759506 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,500

Underlying: Common Stock · 62,500 shares

Expires 2031-01-11

F3 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from January 11, 2021, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

Read SEC document
January 11, 2021 Filed Jan 13, 2021 16:24 UTC
Vexler VladimirChief Scientific Officer
GrantCommon Stock 31,250 $0.00 $0.00
Disclosure

SEC source: 0001567619-21-000983 · doc1.xml · nonDerivative · entry 1

Vexler Vladimir · CIK 0001759506 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,146

F1 · shares: Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3 of the RSUs vest annually on January 11 of each year, with the first 1/3 vesting on January 11, 2022 and with the RSUs being fully vested on January 11, 2024, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

F2 · balance_after: Includes 52,083 RSUs.

Read SEC document
January 11, 2021 Filed Jan 13, 2021 21:31 UTC GrantStock Option (Right to Buy) · Derivative 20,000 $0.00 Strike: $17.58 $0.00
Disclosure

SEC source: 0001567619-21-000990 · doc1.xml · derivative · entry 1

Wahlstrom Mats · CIK 0001459154 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2031-01-11

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from January 1, 2021, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

Read SEC document
January 11, 2021 Filed Jan 13, 2021 16:23 UTC
Viret Jean-FredericChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 62,500 $0.00 Strike: $17.58 $0.00
Disclosure

SEC source: 0001567619-21-000982 · doc1.xml · derivative · entry 2

Viret Jean-Frederic · CIK 0001427569 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,500

Underlying: Common Stock · 62,500 shares

Expires 2031-01-11

F3 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from January 11, 2021, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

Read SEC document
January 11, 2021 Filed Jan 13, 2021 16:23 UTC
Viret Jean-FredericChief Financial Officer
GrantCommon Stock 31,250 $0.00 $0.00
Disclosure

SEC source: 0001567619-21-000982 · doc1.xml · nonDerivative · entry 1

Viret Jean-Frederic · CIK 0001427569 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,439

F1 · shares: Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3 of the RSUs vest annually on January 11 of each year, with the first 1/3 vesting on January 11, 2022 and with the RSUs being fully vested on January 11, 2024, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

F2 · balance_after: Includes 52,083 RSUs.

Read SEC document
January 11, 2021 Filed Jan 13, 2021 21:29 UTC
Szela Mary TDirector
GrantStock Option (Right to Buy) · Derivative 20,000 $0.00 Strike: $17.58 $0.00
Disclosure

SEC source: 0001567619-21-000987 · doc1.xml · derivative · entry 1

Szela Mary T · CIK 0001410289 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2031-01-11

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from January 1, 2021, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

Read SEC document
January 11, 2021 Filed Jan 13, 2021 16:25 UTC GrantStock Option (Right to Buy) · Derivative 20,000 $0.00 Strike: $17.58 $0.00
Disclosure

SEC source: 0001567619-21-000984 · doc1.xml · derivative · entry 1

LAWLIS V BRYAN · CIK 0001247681 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2031-01-11

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from January 1, 2021, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

Read SEC document
January 11, 2021 Filed Jan 13, 2021 16:30 UTC
HEALY JAMESDirector
GrantStock Option (Right to Buy) · Derivative 20,000 $0.00 Strike: $17.58 $0.00
Disclosure

SEC source: 0001567619-21-000989 · doc1.xml · derivative · entry 1

HEALY JAMES · CIK 0001245624 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2031-01-11

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from January 1, 2021, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

Read SEC document
January 11, 2021 Filed Jan 13, 2021 16:26 UTC GrantStock Option (Right to Buy) · Derivative 20,000 $0.00 Strike: $17.58 $0.00
Disclosure

SEC source: 0001567619-21-000985 · doc1.xml · derivative · entry 1

NUSSBAUM SAMUEL R MD · CIK 0001199310 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2031-01-11

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from January 1, 2021, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

Read SEC document
January 11, 2021 Filed Jan 13, 2021 21:27 UTC GrantStock Option (Right to Buy) · Derivative 20,000 $0.00 Strike: $17.58 $0.00
Disclosure

SEC source: 0001567619-21-000986 · doc1.xml · derivative · entry 1

TZOUMAKAS KIMBERLY JO · CIK 0001766666 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2031-01-11

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from January 1, 2021, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

Read SEC document
January 11, 2021 Filed Jan 13, 2021 21:22 UTC
Anicetti Vincent RChief Operating Officer
GrantStock Option (Right to Buy) · Derivative 62,500 $0.00 Strike: $17.58 $0.00
Disclosure

SEC source: 0001567619-21-000981 · doc1.xml · derivative · entry 2

Anicetti Vincent R · CIK 0001733375 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,500

Underlying: Common Stock · 62,500 shares

Expires 2031-01-11

F3 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from January 11, 2021, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

Read SEC document
January 11, 2021 Filed Jan 13, 2021 21:22 UTC
Anicetti Vincent RChief Operating Officer
GrantCommon Stock 31,250 $0.00 $0.00
Disclosure

SEC source: 0001567619-21-000981 · doc1.xml · nonDerivative · entry 1

Anicetti Vincent R · CIK 0001733375 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,739

F1 · shares: Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3 of the RSUs vest annually on January 11 of each year, with the first 1/3 vesting on January 11, 2022 and with the RSUs being fully vested on January 11, 2024, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

F2 · balance_after: Includes 52,083 RSUs.

Read SEC document
January 10, 2021 Filed Jan 12, 2021 16:55 UTC
Vexler VladimirChief Scientific Officer
Tax withholdingCommon Stock 4,080 $18.18 $74,174.40
Disclosure

SEC source: 0001567619-21-000923 · doc1.xml · nonDerivative · entry 1

Vexler Vladimir · CIK 0001759506 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,896

F1 · balance_after: Includes 20,833 restricted stock units.

F2 · balance_after: Includes 1,303 shares acquired on May 15, 2020, pursuant to Issuer's employee stock purchase plan.

Read SEC document
January 10, 2021 Filed Jan 12, 2021 16:55 UTC
Viret Jean-FredericChief Financial Officer
Tax withholdingCommon Stock 4,080 $18.18 $74,174.40
Disclosure

SEC source: 0001567619-21-000922 · doc1.xml · nonDerivative · entry 1

Viret Jean-Frederic · CIK 0001427569 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,189

F1 · balance_after: Includes 20,833 restricted stock units.

Read SEC document
January 10, 2021 Filed Jan 12, 2021 21:53 UTC
Anicetti Vincent RChief Operating Officer
Tax withholdingCommon Stock 4,080 $18.18 $74,174.40
Disclosure

SEC source: 0001567619-21-000921 · doc1.xml · nonDerivative · entry 1

Anicetti Vincent R · CIK 0001733375 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,489

F1 · balance_after: Includes 20,833 restricted stock units.

Read SEC document
January 05, 2021 Filed Jan 7, 2021 16:31 UTC GrantStock Option (Right to Buy) · Derivative 40,000 $0.00 Strike: $16.85 $0.00
Disclosure

SEC source: 0001567619-21-000735 · doc1.xml · derivative · entry 1

MENDELSON ALAN C · CIK 0001073381 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2031-01-05

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/36th of the total number of shares subject to the option in successive, equal monthly installments measured from January 5, 2021, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

Read SEC document
January 05, 2021 Filed Jan 7, 2021 21:32 UTC
STOLPER MARKDirector
GrantStock Option (Right to Buy) · Derivative 40,000 $0.00 Strike: $16.85 $0.00
Disclosure

SEC source: 0001567619-21-000738 · doc1.xml · derivative · entry 1

STOLPER MARK · CIK 0001281961 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2031-01-05

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/36th of the total number of shares subject to the option in successive, equal monthly installments measured from January 5, 2021, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

Read SEC document
December 17, 2020 Filed Dec 21, 2020 21:10 UTC
Anicetti Vincent RChief Operating Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 2,500 $0.00 Strike: $2.50 $0.00
Disclosure

SEC source: 0001567619-20-021405 · doc1.xml · derivative · entry 3

Anicetti Vincent R · CIK 0001733375 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,988

Underlying: Common Stock · 2,500 shares

Expires 2024-06-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: All of the shares underlying this option are vested and exercisable as of the date hereof.

Read SEC document
December 17, 2020 Filed Dec 21, 2020 21:10 UTC
Anicetti Vincent RChief Operating Officer
SaleCommon Stock 2,500 $17.51 $43,780.00
Disclosure

SEC source: 0001567619-20-021405 · doc1.xml · nonDerivative · entry 2

Anicetti Vincent R · CIK 0001733375 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,569

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person.

F3 · price: The transaction was executed in multiple trades in prices ranging from $17.41 to $17.68, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.

F1 · balance_after: Includes 31,250 restricted stock units.

Read SEC document
December 17, 2020 Filed Dec 21, 2020 21:10 UTC
Anicetti Vincent RChief Operating Officer
Exercise / conversionCommon Stock 2,500 $2.50 $6,251.25
Disclosure

SEC source: 0001567619-20-021405 · doc1.xml · nonDerivative · entry 1

Anicetti Vincent R · CIK 0001733375 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,069

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 31,250 restricted stock units.

Read SEC document
December 10, 2020 Filed Dec 11, 2020 16:39 UTC
Vexler VladimirChief Scientific Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 17,626 $0.00 Strike: $2.08 $0.00
Disclosure

SEC source: 0001567619-20-020979 · doc1.xml · derivative · entry 6

Vexler Vladimir · CIK 0001759506 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,356

Underlying: Common Stock · 17,626 shares

Expires 2023-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: All of the shares underlying this option are vested and exercisable as of the date hereof.

Read SEC document
December 10, 2020 Filed Dec 11, 2020 16:39 UTC
Vexler VladimirChief Scientific Officer
SaleCommon Stock 17,626 $18.05 $318,066.46
Disclosure

SEC source: 0001567619-20-020979 · doc1.xml · nonDerivative · entry 4

Vexler Vladimir · CIK 0001759506 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,673

F3 · price: The transaction was executed in multiple trades at prices ranging from $18.00 to $18.13, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.

F1 · balance_after: Includes 31,250 restricted stock units.

Read SEC document
December 10, 2020 Filed Dec 11, 2020 16:39 UTC
Vexler VladimirChief Scientific Officer
Exercise / conversionCommon Stock 17,626 $2.08 $36,729.06
Disclosure

SEC source: 0001567619-20-020979 · doc1.xml · nonDerivative · entry 3

Vexler Vladimir · CIK 0001759506 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,299

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 31,250 restricted stock units.

Read SEC document
December 09, 2020 Filed Dec 11, 2020 16:39 UTC
Vexler VladimirChief Scientific Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 30,000 $0.00 Strike: $2.08 $0.00
Disclosure

SEC source: 0001567619-20-020979 · doc1.xml · derivative · entry 5

Vexler Vladimir · CIK 0001759506 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,982

Underlying: Common Stock · 30,000 shares

Expires 2023-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: All of the shares underlying this option are vested and exercisable as of the date hereof.

Read SEC document
December 09, 2020 Filed Dec 11, 2020 16:39 UTC
Vexler VladimirChief Scientific Officer
SaleCommon Stock 49,512 $18.24 $903,084.03
Disclosure

SEC source: 0001567619-20-020979 · doc1.xml · nonDerivative · entry 2

Vexler Vladimir · CIK 0001759506 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,673

F2 · price: The transaction was executed in multiple trades at prices ranging from $18.00 to $18.61, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.

F1 · balance_after: Includes 31,250 restricted stock units.

Read SEC document
December 09, 2020 Filed Dec 11, 2020 16:39 UTC
Vexler VladimirChief Scientific Officer
Exercise / conversionCommon Stock 30,000 $2.08 $62,514.00
Disclosure

SEC source: 0001567619-20-020979 · doc1.xml · nonDerivative · entry 1

Vexler Vladimir · CIK 0001759506 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,185

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 31,250 restricted stock units.

Read SEC document
December 07, 2020 Filed Dec 9, 2020 22:53 UTC
Anicetti Vincent RChief Operating Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 5,791 $0.00 Strike: $12.70 $0.00
Disclosure

SEC source: 0001567619-20-020818 · doc1.xml · derivative · entry 5

Anicetti Vincent R · CIK 0001733375 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,791 shares

Expires 2027-08-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: All of the shares underlying this option are vested and exercisable as of the date hereof.

Read SEC document
December 07, 2020 Filed Dec 9, 2020 22:53 UTC
Anicetti Vincent RChief Operating Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 3,000 $0.00 Strike: $12.37 $0.00
Disclosure

SEC source: 0001567619-20-020818 · doc1.xml · derivative · entry 4

Anicetti Vincent R · CIK 0001733375 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 123,000

Underlying: Common Stock · 3,000 shares

Expires 2029-01-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from January 11, 2019, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

Read SEC document
December 07, 2020 Filed Dec 9, 2020 22:53 UTC
Anicetti Vincent RChief Operating Officer
SaleCommon Stock 8,791 $18.42 $161,895.94
Disclosure

SEC source: 0001567619-20-020818 · doc1.xml · nonDerivative · entry 3

Anicetti Vincent R · CIK 0001733375 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,569

F2 · price: The transaction was executed in multiple trades in prices ranging from $18.30 to $18.83, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.

F1 · balance_after: Includes 31,250 restricted stock units.

Read SEC document
December 07, 2020 Filed Dec 9, 2020 22:53 UTC
Anicetti Vincent RChief Operating Officer
Exercise / conversionCommon Stock 5,791 $12.70 $73,545.70
Disclosure

SEC source: 0001567619-20-020818 · doc1.xml · nonDerivative · entry 2

Anicetti Vincent R · CIK 0001733375 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,360

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 31,250 restricted stock units.

Read SEC document
December 07, 2020 Filed Dec 9, 2020 22:53 UTC
Anicetti Vincent RChief Operating Officer
Exercise / conversionCommon Stock 3,000 $12.37 $37,110.00
Disclosure

SEC source: 0001567619-20-020818 · doc1.xml · nonDerivative · entry 1

Anicetti Vincent R · CIK 0001733375 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,569

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 31,250 restricted stock units.

Read SEC document
December 04, 2020 Filed Dec 7, 2020 21:51 UTC
Anicetti Vincent RChief Operating Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 16,709 $0.00 Strike: $12.70 $0.00
Disclosure

SEC source: 0001567619-20-020705 · doc1.xml · derivative · entry 10

Anicetti Vincent R · CIK 0001733375 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,791

Underlying: Common Stock · 16,709 shares

Expires 2027-08-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: All of the shares underlying this option are vested and exercisable as of the date hereof.

Read SEC document
December 04, 2020 Filed Dec 7, 2020 21:51 UTC
Anicetti Vincent RChief Operating Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 32,291 $0.00 Strike: $16.75 $0.00
Disclosure

SEC source: 0001567619-20-020705 · doc1.xml · derivative · entry 9

Anicetti Vincent R · CIK 0001733375 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,709

Underlying: Common Stock · 32,291 shares

Expires 2028-05-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from May 1, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

Read SEC document
December 04, 2020 Filed Dec 7, 2020 21:51 UTC
Anicetti Vincent RChief Operating Officer
SaleCommon Stock 49,000 $18.85 $923,694.10
Disclosure

SEC source: 0001567619-20-020705 · doc1.xml · nonDerivative · entry 6

Anicetti Vincent R · CIK 0001733375 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,569

F3 · price: The transaction was executed in multiple trades in prices ranging from $18.565 to $19.01, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.

F1 · balance_after: Includes 31,250 restricted stock units.

Read SEC document
December 04, 2020 Filed Dec 7, 2020 21:51 UTC
Anicetti Vincent RChief Operating Officer
Exercise / conversionCommon Stock 16,709 $12.70 $212,204.30
Disclosure

SEC source: 0001567619-20-020705 · doc1.xml · nonDerivative · entry 5

Anicetti Vincent R · CIK 0001733375 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,569

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 31,250 restricted stock units.

Read SEC document
December 04, 2020 Filed Dec 7, 2020 21:51 UTC
Anicetti Vincent RChief Operating Officer
Exercise / conversionCommon Stock 32,291 $16.75 $540,874.25
Disclosure

SEC source: 0001567619-20-020705 · doc1.xml · nonDerivative · entry 4

Anicetti Vincent R · CIK 0001733375 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,860

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 31,250 restricted stock units.

Read SEC document
December 03, 2020 Filed Dec 7, 2020 21:51 UTC
Anicetti Vincent RChief Operating Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 13,020 $0.00 Strike: $17.73 $0.00
Disclosure

SEC source: 0001567619-20-020705 · doc1.xml · derivative · entry 8

Anicetti Vincent R · CIK 0001733375 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,480

Underlying: Common Stock · 13,020 shares

Expires 2030-01-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from January 10, 2020, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

Read SEC document
December 03, 2020 Filed Dec 7, 2020 21:51 UTC
Anicetti Vincent RChief Operating Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 36,736 $0.00 Strike: $17.17 $0.00
Disclosure

SEC source: 0001567619-20-020705 · doc1.xml · derivative · entry 7

Anicetti Vincent R · CIK 0001733375 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 36,736 shares

Expires 2026-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: All of the shares underlying this option are vested and exercisable as of the date hereof.

Read SEC document
December 03, 2020 Filed Dec 7, 2020 21:51 UTC
Anicetti Vincent RChief Operating Officer
SaleCommon Stock 49,756 $18.67 $929,078.86
Disclosure

SEC source: 0001567619-20-020705 · doc1.xml · nonDerivative · entry 3

Anicetti Vincent R · CIK 0001733375 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,569

F2 · price: The transaction was executed in multiple trades in prices ranging from $18.58 to $18.86, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.

F1 · balance_after: Includes 31,250 restricted stock units.

Read SEC document
December 03, 2020 Filed Dec 7, 2020 21:51 UTC
Anicetti Vincent RChief Operating Officer
Exercise / conversionCommon Stock 13,020 $17.73 $230,844.60
Disclosure

SEC source: 0001567619-20-020705 · doc1.xml · nonDerivative · entry 2

Anicetti Vincent R · CIK 0001733375 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,325

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 31,250 restricted stock units.

Read SEC document
December 03, 2020 Filed Dec 7, 2020 21:51 UTC
Anicetti Vincent RChief Operating Officer
Exercise / conversionCommon Stock 36,736 $17.17 $630,757.12
Disclosure

SEC source: 0001567619-20-020705 · doc1.xml · nonDerivative · entry 1

Anicetti Vincent R · CIK 0001733375 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,305

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 31,250 restricted stock units.

Read SEC document
November 18, 2020 Filed Nov 19, 2020 21:16 UTC
Anicetti Vincent RChief Operating Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 4,283 $0.00 Strike: $12.70 $0.00
Disclosure

SEC source: 0001567619-20-020096 · doc1.xml · derivative · entry 8

Anicetti Vincent R · CIK 0001733375 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,500

Underlying: Common Stock · 4,283 shares

Expires 2027-08-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: All of the shares underlying this option are vested and exercisable as of the date hereof.

Read SEC document
November 18, 2020 Filed Nov 19, 2020 21:16 UTC
Anicetti Vincent RChief Operating Officer
SaleCommon Stock 4,283 $18.00 $77,094.00
Disclosure

SEC source: 0001567619-20-020096 · doc1.xml · nonDerivative · entry 6

Anicetti Vincent R · CIK 0001733375 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,569

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person.

F1 · balance_after: Includes 31,250 restricted stock units.

Read SEC document
November 18, 2020 Filed Nov 19, 2020 21:16 UTC
Anicetti Vincent RChief Operating Officer
Exercise / conversionCommon Stock 4,283 $12.70 $54,394.10
Disclosure

SEC source: 0001567619-20-020096 · doc1.xml · nonDerivative · entry 5

Anicetti Vincent R · CIK 0001733375 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,852

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 31,250 restricted stock units.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.